BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
ESYN
HWH International Inc.
There isn't enough reported data to score ESYN yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
ESYN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Strong |
ESYN's balance sheet is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its revenue.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
ESYN PE Valuation
ESYN has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
ESYN Forward outlook
There aren't enough analyst estimates for ESYN to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
ESYN Earnings Per Share
ESYN and BABA do not have enough comparable growth data to identify a winner.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over ESYN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
ESYN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $64.2K | -79% |
| Q4 2025 | $54.6K | -81% |
| Q3 2025 | $206.8K | -40% |
| Q2 2025 | $310.4K | -7.3% |
| Q3 2024 | $345.5K | +52% |
| Q2 2024 | $334.9K | +48% |
| Q2 2022 | $66.5K | -96% |
| Q1 2022 | $647.7K | -62% |
ESYN's revenue has slid since its 2021 peak: $64,200 last quarter, down 79% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 328% | +304 points |
| Q1 2026 | -976% | N/A |
| Q4 2025 | -3569% | -3455 points |
| Q3 2025 | -143% | +13 points |
| Q2 2025 | 24% | +145 points |
| Q4 2024 | -115% | N/A |
| Q3 2024 | -155% | +19 points |
| Q2 2024 | -121% | N/A |
ESYN has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
ESYN has the stronger cash trend. Its trailing FCF is up 8.7% versus its history, compared with BABA at down 158%.
ESYN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1M | -$765.8K |
| Q3 2025 | -$217.9K | +$59.2K |
| Q4 2024 | -$256.2K | -$25.7K |
| Q3 2024 | -$277.1K | +$196.7K |
| Q2 2024 | -$516.8K | -$43K |
| Q3 2023 | -$473.8K | -$367.6K |
| Q3 2022 | -$106.2K | +$364.7K |
| Q2 2022 | -$88.6K | -113% |
ESYN has burned cash in most quarters: −$955,254 over the past year, against −$2M the year before.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over ESYN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
ESYN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +63.2K shares |
| 1 year | +16% | +1.1M shares |
| 3 years | +235% | +5.3M shares |
ESYN has 8M diluted shares, up 16% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | $1.00 |
| Q3 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
ESYN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -0.7x | Net Cash |
ESYN has more cash than debt.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
ESYN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 23.9 | Neutral |
ESYN's weekly RSI is 44 (neutral) and its Stochastic is 24 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
ESYN PE vs Consumer Cyclical Sector
ESYN has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
ESYN has stronger trend alignment. BABA is above 0 of 5 weekly averages versus ESYN above 0 of 4.
ESYN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.92 | 24% below |
| 20 week MA | $1.78 | 19% below |
| 50 week MA | $1.55 | 6.5% below |
| 100 week MA | $1.67 | 13% below |
ESYN is in a downtrend: it's below all four of its weekly moving averages, and 13% below its 100-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
ESYN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.3 | $3.18 | -69% |
| 2025 | $3.18 | $1.49 | -53% |
| 2026 YTD | $1.49 | $1.45 | -2.7% |
ESYN has the edge over BABA on returns for 2026, with the stronger performance.